If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Strategic Review

14 Mar 2024 07:00

RNS Number : 7782G
Amati AIM VCT PLC
14 March 2024
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICITON WHERE TO DO SO WOULD COSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THE JURISDICITON.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATON FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. ON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

For immediate release

14 March 2024

Amati AIM VCT plc

 

Strategic review

 

The Board of Amati AIM VCT plc (the "Company") confirms that it has, in conjunction with the Company's investment manager, Amati Global Investors Limited (the "Investment Manager"), been considering the Company's strategic options in the light of ongoing challenges in the AIM market and the resultant performance issues faced by the Company. As part of this review, the Board intends to consider whether the Company's investment strategy should be expanded to facilitate investment in a broader range of securities while continuing to comply with the rules applicable to VCTs. 

 

The Board also notes the recent announcement of a recommended offer (the "Offer") for Mattioli Woods plc by Tiger Bidco Limited (owned by funds managed by Pollen Street Capital Limited). Mattioli Woods plc currently owns 49% of the issued share capital of the Investment Manager. The ongoing review of strategic options will take into account any possible impact of the Offer on the Company and the management of its investment portfolio.

 

Further details of the strategic review will be included in the Company's annual report and accounts which are expected to be published shortly.

 

Enquiries:

 

Fiona Wollocombe, Chair

Amati AIM VCT plc

Email: info@amatiglobal.com

 

Douglas Armstrong

Dickson Minto Advisers

Financial Adviser to the Company

Telephone: 020 7649 6823

 

Important Information

This announcement is released by the Company and the information contained within this announcement is deemed by the Company to constitute inside information for the purposes of Article 7 of the UK version of the EU Market Abuse Regulation (Regulation (EU) No.596/2014) which forms part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended. Upon the publication of this announcement via a Regulatory Information Service, such information is now considered to be in the public domain.

Legal Entity Identifier (LEI): 213800HAEDBBK9RWCD25

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSFMFUDELSEID
Date   Source Headline
8th Jan 20209:52 amRNSHolding(s) in Company
3rd Jan 20208:01 amRNSTotal Voting Rights
3rd Jan 20207:57 amRNSNet Asset Value(s)
20th Dec 20193:14 pmRNSNet Asset Value(s)
16th Dec 201912:09 pmRNSNet Asset Value(s)
10th Dec 20192:54 pmRNSTransaction in Own Shares
10th Dec 201912:16 pmRNSDirector/PDMR Shareholding
10th Dec 201912:08 pmRNSIssue of Equity
9th Dec 201910:06 amRNSNet Asset Value(s)
2nd Dec 20194:44 pmRNSNet Asset Value(s)
2nd Dec 20192:44 pmRNSTransaction in Own Shares
2nd Dec 201910:13 amRNSTotal Voting Rights
26th Nov 20192:43 pmRNSDirector/PDMR Shareholding
26th Nov 201912:39 pmRNSIssue of Equity
25th Nov 20192:34 pmRNSTransaction in Own Shares
22nd Nov 20195:18 pmRNSDirector/PDMR Shareholding
22nd Nov 20194:05 pmRNSIssue of Equity
22nd Nov 20191:40 pmRNSNet Asset Value(s)
22nd Nov 20197:00 amRNSHolding(s) in Company
18th Nov 20193:51 pmRNSTransaction in Own Shares
18th Nov 201911:53 amRNSNet Asset Value(s)
8th Nov 20195:24 pmRNSNet Asset Value(s)
4th Nov 201911:54 amRNSNet Asset Value(s)
1st Nov 20199:34 amRNSTotal Voting Rights
31st Oct 20195:02 pmRNSOffer for subscription
28th Oct 201912:25 pmRNSTransaction in Own Shares
28th Oct 201911:50 amRNSNet Asset Value(s)
18th Oct 20194:16 pmRNSNet Asset Value(s)
16th Oct 201911:29 amRNSTransaction in Own Shares
16th Oct 201910:23 amRNSNet Asset Value(s)
8th Oct 20192:07 pmRNSHalf-year Report
8th Oct 20191:33 pmRNSDividend Declaration
7th Oct 201910:09 amRNSNet Asset Value(s)
1st Oct 20195:20 pmRNSNet Asset Value(s)
1st Oct 20199:20 amRNSTotal Voting Rights
25th Sep 20192:41 pmRNSTransaction in Own Shares
20th Sep 20194:41 pmRNSNet Asset Value(s)
17th Sep 201910:22 amRNSTransaction in Own Shares
16th Sep 20193:25 pmRNSNet Asset Value(s)
10th Sep 20191:08 pmRNSTransaction in Own Shares
6th Sep 20195:34 pmRNSNet Asset Value(s)
2nd Sep 20195:18 pmRNSNet Asset Value(s)
2nd Sep 20198:05 amRNSTotal Voting Rights
30th Aug 20196:17 pmRNSHolding(s) in Company
28th Aug 20197:00 amRNSUpdate on offer for subscription
27th Aug 20192:27 pmRNSNet Asset Value(s)
23rd Aug 20191:41 pmRNSTransaction in Own Shares
20th Aug 20192:33 pmRNSTransaction in Own Shares
19th Aug 20192:06 pmRNSNet Asset Value(s)
15th Aug 20195:17 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.